A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women

NCT03270969 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

HIV Prevention

Interventions

DRUG: Tenofovir Disoproxil Fumarate/Emtricitabine

Sponsor

University of Nebraska